journal article·2016-07-26Open access

Tuning the Selectivity of Dendron Micelles Through Variations of the Poly(ethylene glycol) Corona

Ryan M. Pearson, Soumyo Sen, Hao-jui Hsu, Matt Pasko, Marilyn Gaske, Petr Král, Seungpyo Hong

ACS Nano· Volume 10· Issue 7

Abstract

Engineering controllable cellular interactions into nanoscale drug delivery systems is key to enable their full potential. Here, using folic acid (FA) as a model targeting ligand and dendron micelles (DM) as a nanoparticle (NP) platform, we present a comprehensive experimental and modeling investigation of the structural properties of DMs that govern the formation of controllable, FA-mediated cellular interactions. Our experimental results demonstrate that a high level of control over the specific cell interactions of FA-targeted DMs can be achieved through modulation of the PEG corona length and the FA content. Using various molecular weight PEGs (0.6K, 1K, and 2K g/mol) and contents of dendron-FA conjugate incorporated into DMs (0, 5, 10, 25 wt %), the cell interactions of the targeted DMs could be controlled to exhibit minimal to >25-fold enhancement over nontargeted DMs. Molecular dynamics simulations indicated that structural characteristics, such as solvent accessible surface area of FA, local PEG density near FA, and FA mobility, account in part for the experimental differences in cellular interactions. The molecular structure that allows FA to depart from the surface of DMs to facilitate the initial cell surface binding was revealed to be the most important contributor for determining FA-mediated cellular interactions of DMs. The modular properties of DMs in controlling their specific cell interactions support the potential of DMs as a delivery platform and offer design cues for future development of targeted NPs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Dendrimers and Hyperbranched Polymers · RNA Interference and Gene Delivery · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biopharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois 60612, United States

Funding

National Cancer Institute · Camille and Henry Dreyfus Foundation · Alex's Lemonade Stand Foundation for Childhood Cancer · Leukemia and Lymphoma Society · Division of Materials Research · University of Illinois at Chicago · Hans W. Vahlteich Research Fund, University of Illinois at Chicago · College of Liberal Arts and Sciences, University of Illinois at Chicago

References (45)

Show source-provided references
1. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
2. 10.4155/tde.12.7610.4155/tde.12.76 ↗
3. 10.1557/mrs.2014.910.1557/mrs.2014.9 ↗
4. 10.1016/j.ijpharm.2005.10.01010.1016/j.ijpharm.2005.10.010 ↗
5. 10.1021/ja208433810.1021/ja2084338 ↗
6. 10.1021/nl302638g10.1021/nl302638g ↗
7. 10.3389/fchem.2014.0010810.3389/fchem.2014.00108 ↗
8. 10.1016/j.addr.2008.08.00510.1016/j.addr.2008.08.005 ↗
9. 10.1038/nrd261410.1038/nrd2614 ↗
10. 10.1021/bc980112410.1021/bc9801124 ↗
11. 10.1021/nn301630n10.1021/nn301630n ↗
12. 10.1021/nn305663e10.1021/nn305663e ↗
13. 10.1080/1061186080223024010.1080/10611860802230240 ↗
14. Lee R. J. · J. Biol. Chem. · 1994 · 269 · 319810.1016/S0021-9258(17)41848-5 ↗
15. 10.1016/j.addr.2004.01.01110.1016/j.addr.2004.01.011 ↗
16. 10.1158/1078-0432.CCR-08-015910.1158/1078-0432.CCR-08-0159 ↗
17. 10.1021/nn403395410.1021/nn4033954 ↗
18. 10.1039/c1cc14331j10.1039/c1cc14331j ↗
19. 10.1021/mz300533w10.1021/mz300533w ↗
20. 10.1021/ma501258c10.1021/ma501258c ↗
21. 10.1002/anie.20151173310.1002/anie.201511733 ↗
22. 10.1016/j.chembiol.2006.11.01510.1016/j.chembiol.2006.11.015 ↗
23. 10.1002/anie.20110550810.1002/anie.201105508 ↗
24. 10.1002/anie.20100344510.1002/anie.201003445 ↗
25. 10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S10.1002/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S ↗
26. Weitman S. D. · Cancer Res. · 1992 · 52 · 3396
27. 10.1016/S0169-409X(99)00062-910.1016/S0169-409X(99)00062-9 ↗
28. 10.1021/bm300316n10.1021/bm300316n ↗
29. 10.1021/mp300560n10.1021/mp300560n ↗
30. 10.1021/acs.molpharmaceut.5b0094610.1021/acs.molpharmaceut.5b00946 ↗
31. 10.1021/mp500096710.1021/mp5000967 ↗
32. 10.1038/nature1232710.1038/nature12327 ↗
33. 10.1016/j.biomaterials.2011.04.07810.1016/j.biomaterials.2011.04.078 ↗
34. 10.1126/science.275.5301.82010.1126/science.275.5301.820 ↗
35. Beer J. H. · Blood · 1992 · 79 · 11710.1182/blood.V79.1.117.117 ↗
36. 10.1038/nnano.2012.23710.1038/nnano.2012.237 ↗
37. 10.1002/anie.20130946410.1002/anie.201309464 ↗
38. 10.1021/acsnano.5b0132610.1021/acsnano.5b01326 ↗
39. 10.1002/jbm.a.3153710.1002/jbm.a.31537 ↗
40. 10.1002/jcc.2028910.1002/jcc.20289 ↗
41. 10.1021/jp973084f10.1021/jp973084f ↗
42. 10.1529/biophysj.108.13302510.1529/biophysj.108.133025 ↗
43. 10.1002/jcc.2136710.1002/jcc.21367 ↗
44. 10.1002/andp.1921369030410.1002/andp.19213690304 ↗
45. 10.1016/0263-7855(96)00018-510.1016/0263-7855(96)00018-5 ↗